Hiroshi Hirosawa
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Increasing Ablation Area Using the Arfa Ablation System: An Experimental Study in the Bovine Liver.
Journal: In vivo (Athens, Greece)
Published: March 01, 2026
Suppression of popping rates in radiofrequency ablation under perfluorobutane microbubbles for hepatocellular carcinoma.
Journal: Clinical and experimental hepatology
Published: May 26, 2024
Serum zinc concentration as a potential predictor of presarcopenia in patients with chronic liver disease: a preliminary study.
Journal: Translational gastroenterology and hepatology
Published: September 19, 2023
Comparison of Ablation Volume Between Emprint® and Mimapro® Systems for Hepatocellular Carcinoma -A Preliminary Study.
Journal: Journal of hepatocellular carcinoma
Published: March 29, 2023
Ex Vivo Experimental Study of the Ablation Area of Bovine Liver Using STARmed Radiofrequency Ablation.
Journal: In vivo (Athens, Greece)
Published: March 15, 2023
An Investigation of Popping During Radiofrequency Ablation After Lenvatinib Administration for Hepatocellular Carcinoma.
Journal: In vivo (Athens, Greece)
Published: January 11, 2023
Optimal Skeletal Muscle Mass Index Cut-Off Values for Presarcopenia Evaluated by Computed Tomography against Dual-Energy X-ray Absorptiometry in Patients with Chronic Liver Disease.
Journal: Journal of clinical medicine
Published: February 22, 2021
Effect of levocarnitine administration in patients with chronic liver disease.
Journal: Experimental and therapeutic medicine
Published: March 05, 2020
Efficacy of Physical Activity in Prevention of Muscle Weakness in Patients With Chronic Liver Disease.
Journal: Journal of clinical medicine research
Published: September 02, 2019
Relationship between pre-sarcopenia and quality of life in patients with chronic liver disease: a cross-sectional study.
Journal: European journal of gastroenterology & hepatology
Published: April 10, 2019
Health-related quality of life on the clinical course of patients with chronic hepatitis C receiving daclatasvir/asunaprevir therapy: A prospective observational study comparing younger (<70) and elderly (≥70) patients.
Journal: Experimental and therapeutic medicine
Published: June 04, 2017
Evaluation of the health-related quality of life using the 36-item short form health survey in patients with chronic hepatitis C receiving pegylated interferon/ribavirin/telaprevir triple treatment.
Journal: Experimental and therapeutic medicine
Published: October 06, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026